Mental Health Clinics in Palos Verdes Estates, CA Accepting Medicare
7 Mental Health Clinics found. Showing 1 - 7
 Hands In Hands Consulting Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 605 Paseo Del Mar, Palos Verdes Estates, CA 90274 Phone: 310-634-6354 Fax: 424-214-1190 |
Hands In Hands Recovery Center Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 605 Paseo Del Mar, Palos Verdes Estates, CA 90274 Phone: 310-634-6354 Fax: 424-214-1190 |
Malia Prietto Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 336 Tejon Pl, Palos Verdes Estates, CA 90274 Phone: 424-757-4957 |
Neurobehavioral Medical Group Inc Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 716 Yarmouth Rd Ste 203, Palos Verdes Estates, CA 90274 Phone: 310-377-3070 |
Melvyn M. Lewin, Phd Psychological Corp Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 716 Yarmouth Rd, Suite D, Palos Verdes Estates, CA 90274 Phone: 310-377-1198 Fax: 310-791-9627 |
Hearts Respond Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 336 Tejon Place, Palos Verdes Estates, CA 90274 Phone: 323-902-7534 |
Carol A Lindberg Md Incorporated Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 344 Tejon Pl, Palos Verdes Estates, CA 90274 Phone: 310-378-0565 |
News Archive
Reumofan Plus may have harmful pharmaceutical ingredients, warns FDA
The U.S. Food and Drug Administration is warning consumers that Reumofan Plus, marketed as a "natural" dietary supplement for pain relief and other serious conditions, contains several active pharmaceutical ingredients not listed on the label that could be harmful.
MD Anderson and Varian announce strategic collaboration to optimize radiation oncology treatment
The University of Texas MD Anderson Cancer Center and Varian today announced a new strategic collaboration to develop an integrated software platform to streamline review of radiation oncology treatment plans.
UTILITY receives FDA approval for Investigational New Drug applications
UTILITY therapeutics Ltd, a pharmaceutical company focused on developing and commercializing antibiotics in the US, today announces that the US Food and Drug Administration has approved the Investigational New Drug applications for mecillinam and pivmecillinam.
Minnesota clinics serving many more thanks to stimulus dollars
As Minnesota braces for some cuts to public health programs, the state's network of community health centers is being buoyed by money from the federal stimulus that will expand coverage to the un- and underinsured in that state, The Minnesota Post reports.
› Verified 6 days ago